Intervac, L.l.c. - Net Worth and Insider Trading
Intervac, L.l.c. Net Worth
The estimated net worth of Intervac, L.l.c. is at least $0 dollars as of 2024-11-06. Intervac, L.l.c. is the 10% Owner of Emergent BioSolutions Inc and owns about 0 shares of Emergent BioSolutions Inc (EBS) stock worth over $0. Details can be seen in Intervac, L.l.c.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Intervac, L.l.c. has not made any transactions after 2011-04-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Intervac, L.l.c.
Intervac, L.l.c. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Intervac, L.l.c. owns 2 companies in total, including Aptevo Therapeutics Inc (APVO) , and Emergent BioSolutions Inc (EBS) .
Click here to see the complete history of Intervac, L.l.c.’s form 4 insider trades.
Insider Ownership Summary of Intervac, L.l.c.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APVO | Aptevo Therapeutics Inc | 2016-08-01 | 10 percent owner |
| EBS | Emergent BioSolutions Inc | 2011-04-18 | 10 percent owner |
Intervac, L.l.c. Latest Holdings Summary
Intervac, L.l.c. currently owns a total of 1 stock. Intervac, L.l.c. owns 0 shares of Emergent BioSolutions Inc (EBS) as of April 18, 2011, with a value of $0.
Latest Holdings of Intervac, L.l.c.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc | 2011-04-18 | 0 | 8.96 | 0 |
Holding Weightings of Intervac, L.l.c.
Intervac, L.l.c. Form 4 Trading Tracker
According to the SEC Form 4 filings, Intervac, L.l.c. has made a total of 0 transactions in Emergent BioSolutions Inc (EBS) over the past 5 years. The most-recent trade in Emergent BioSolutions Inc is the sale of 7,000 shares on April 18, 2011, which brought Intervac, L.l.c. around $163,170.
Insider Trading History of Intervac, L.l.c.
- 1
Intervac, L.l.c. Trading Performance
Intervac, L.l.c. Ownership Network
Ownership Network List of Intervac, L.l.c.
Ownership Network Relation of Intervac, L.l.c.
Intervac, L.l.c. Owned Company Details
What does Aptevo Therapeutics Inc do?
Who are the key executives at Aptevo Therapeutics Inc?
Intervac, L.l.c. is the 10 percent owner of Aptevo Therapeutics Inc. Other key executives at Aptevo Therapeutics Inc include SVP & CFO Daphne Taylor , 10 percent owner Kevin C Tang , and See Remarks Soyoung Kwon .
Aptevo Therapeutics Inc (APVO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aptevo Therapeutics Inc (APVO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aptevo Therapeutics Inc (APVO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aptevo Therapeutics Inc (APVO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aptevo Therapeutics Inc Insider Transactions
Intervac, L.l.c. Mailing Address
Above is the net worth, insider trading, and ownership report for Intervac, L.l.c.. You might contact Intervac, L.l.c. via mailing address: C/o East-west Resources Corporation, 12001 Glen Road, Rockville Md 20854.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
